UBS Group’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.9M Sell
104,114
-29,203
-22% -$8.39M 0.01% 1556
2025
Q1
$41.1M Buy
133,317
+38,251
+40% +$11.8M 0.01% 1311
2024
Q4
$33.5M Sell
95,066
-4,071
-4% -$1.44M 0.01% 1372
2024
Q3
$35.5M Buy
99,137
+17,361
+21% +$6.22M 0.01% 984
2024
Q2
$26M Buy
81,776
+2,139
+3% +$681K 0.01% 1076
2024
Q1
$18.3M Buy
79,637
+14,963
+23% +$3.44M ﹤0.01% 1250
2023
Q4
$14.2M Buy
64,674
+7,020
+12% +$1.54M ﹤0.01% 1275
2023
Q3
$13M Sell
57,654
-2,481
-4% -$560K ﹤0.01% 1260
2023
Q2
$13.3M Sell
60,135
-6,544
-10% -$1.44M ﹤0.01% 1277
2023
Q1
$14.9M Buy
66,679
+11,679
+21% +$2.62M 0.01% 1169
2022
Q4
$15.3M Buy
55,000
+12,901
+31% +$3.59M 0.01% 1151
2022
Q3
$8.82M Sell
42,099
-25,694
-38% -$5.38M ﹤0.01% 1368
2022
Q2
$16M Buy
67,793
+14,087
+26% +$3.32M 0.01% 1086
2022
Q1
$9.64M Sell
53,706
-31,733
-37% -$5.69M ﹤0.01% 1479
2021
Q4
$18.5M Buy
85,439
+39,794
+87% +$8.6M 0.01% 1166
2021
Q3
$8.43M Sell
45,645
-65,778
-59% -$12.1M ﹤0.01% 1622
2021
Q2
$20M Buy
111,423
+68,746
+161% +$12.3M 0.01% 1108
2021
Q1
$7.14M Buy
42,677
+22,510
+112% +$3.76M ﹤0.01% 1682
2020
Q4
$3.06M Sell
20,167
-38,234
-65% -$5.8M ﹤0.01% 2256
2020
Q3
$5.9M Buy
58,401
+18,981
+48% +$1.92M ﹤0.01% 1592
2020
Q2
$4.77M Buy
39,420
+38,308
+3,445% +$4.64M ﹤0.01% 1641
2020
Q1
$106K Sell
1,112
-1,404
-56% -$134K ﹤0.01% 4391
2019
Q4
$221K Sell
2,516
-54,558
-96% -$4.79M ﹤0.01% 4539
2019
Q3
$4.55M Buy
57,074
+51,670
+956% +$4.12M ﹤0.01% 1921
2019
Q2
$422K Sell
5,404
-83,944
-94% -$6.56M ﹤0.01% 3646
2019
Q1
$10.5M Sell
89,348
-22,504
-20% -$2.64M ﹤0.01% 1325
2018
Q4
$12.2M Buy
111,852
+94,367
+540% +$10.3M 0.01% 1105
2018
Q3
$2.24M Buy
17,485
+13,914
+390% +$1.78M ﹤0.01% 2533
2018
Q2
$404K Sell
3,571
-54,630
-94% -$6.18M ﹤0.01% 3684
2018
Q1
$6.54M Buy
58,201
+51,092
+719% +$5.74M ﹤0.01% 1662
2017
Q4
$1.05M Sell
7,109
-11,369
-62% -$1.68M ﹤0.01% 2987
2017
Q3
$2.17M Sell
18,478
-1,862
-9% -$218K ﹤0.01% 2435
2017
Q2
$2.64M Sell
20,340
-9,088
-31% -$1.18M ﹤0.01% 2187
2017
Q1
$3.98M Sell
29,428
-18,720
-39% -$2.53M ﹤0.01% 1799
2016
Q4
$6.91M Buy
48,148
+471
+1% +$67.6K ﹤0.01% 1352
2016
Q3
$5.63M Buy
47,677
+26,941
+130% +$3.18M ﹤0.01% 1467
2016
Q2
$2.2M Sell
20,736
-9,467
-31% -$1M ﹤0.01% 2121
2016
Q1
$3.37M Sell
30,203
-29,313
-49% -$3.27M ﹤0.01% 1750
2015
Q4
$9.32M Buy
59,516
+17,824
+43% +$2.79M 0.01% 1116
2015
Q3
$5.47M Sell
41,692
-22,087
-35% -$2.9M ﹤0.01% 1422
2015
Q2
$11.1M Buy
63,779
+23,437
+58% +$4.08M 0.01% 1090
2015
Q1
$6.96M Buy
40,342
+18,015
+81% +$3.11M ﹤0.01% 1393
2014
Q4
$2.89M Buy
+22,327
New +$2.89M ﹤0.01% 1977